Importance The coronavirus disease 2019 (COVID-19) pandemic is threatening billions of
people worldwide. Tocilizumab has shown promising results in retrospective studies in …

Context If access to effective palliative care is to extend beyond cancer patients, an
understanding of the comparative prevalence of palliative care problems among cancer and non-…

Populations around the world are ageing, and more people are living with the effects of
serious chronic illness towards the end of life. Meeting their needs presents a public health …

Objective: To describe actual and preferred place of death of Italian cancer patients and to
analyse the preferences met regarding the place of death. Design: Mortality follow back …

Introduction. There are 1.7 million deaths from cancer in Europe each year and by 2020 the
World Health Organisation (WHO) estimates that, globally, more than 15 million people will …

Background: Palliative care is an important component of health care in pandemics, contributing
to symptom control, psychological support, and supporting triage and complex decision …

Background Weight loss limits cancer therapy, quality of life and survival. Common diagnostic
criteria and a framework for a classification system for cancer cachexia were recently …

Globally, the number of people affected by coronavirus disease 2019 (COVID-19) is rapidly
increasing. In most (>80%), the illness is relatively mild and can be self-managed out of …

Severe pruritus may be an idiopathic phenomenon or associated with advanced systemic
disease. It is one of the most distressing and difficult to treat symptoms. Uncontrolled studies …

Background Tocilizumab blocks pro-inflammatory activity of interleukin-6 (IL-6), involved in
pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients. Methods …